THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS

Objective: to study the time course of changes in acute-phase parameters and in the levels of autoantibodies, B lymphocytes, immunoglobulin (Ig) classes G, M, and A in patients with rheumatoid arthritis (RA) 2, 8, 16, and 24 weeks after initiation of therapy with rituximab (RTM).

Bibliographic Details
Main Authors: Elena Nikolayevna Aleksandrova, A S Avdeyeva, G V Lukina, A A Novikov, M V Cherkasova, T V Popkova, O G Lineva, G Kh Kuzikyants, E L Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2012-02-01
Series:Научно-практическая ревматология
Subjects:
rheumatoid arthritis
rituximab
erythrocyte sedimentation rate
c-reactive protein
igm/iga rheumatoid factors
anti-cyclic citrullinated peptide antibodies
anti-modified citrullinated vimentin antibodies
cd19+ b lymphocytes
Online Access:https://rsp.mediar-press.net/rsp/article/view/636

Internet

https://rsp.mediar-press.net/rsp/article/view/636

Similar Items